NCT03995563 is a Phase 4 clinical trial of Dexamethasone in Neuralgia,Postherpetic, sponsored by Korea University Guro Hospital.

Who is sponsoring NCT03995563?

NCT03995563 is sponsored by Korea University Guro Hospital.

What drugs are being tested in NCT03995563?

Interventions in NCT03995563: Dexamethasone, Ropivacaine.

What condition does NCT03995563 study?

NCT03995563 studies Neuralgia,Postherpetic.

Is NCT03995563 still recruiting?

NCT03995563 is currently status unknown. Last updated 24 June 2019.

Last reviewed 2019-06-24 · How we verify

NCT03995563

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Epidural Steroid Use in Patients With Continous Epidural Block in PHN Patients.

Status unknown Phase 4 Last updated 24 June 2019

What this trial tests

Phase 4 trial testing Dexamethasone in Neuralgia,Postherpetic in 40 participants. Status unknown.

Timeline

15 May 2019

Primary endpoint
30 May 2020

30 November 2020

Quick facts

Lead sponsor	Korea University Guro Hospital
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	15 May 2019
Primary completion	30 May 2020
Estimated completion	30 November 2020
Sites	1 location across South Korea

Drugs / interventions tested

Dexamethasone (dexamethasone) — full drug profile →
Ropivacaine (ROPIVACAINE) — full drug profile →

Conditions studied

Neuralgia,Postherpetic — all drugs for Neuralgia,Postherpetic →

Sponsor

Korea University Guro Hospital

Who can join

Adults 18 to 80, any sex, with Neuralgia,Postherpetic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The efficiency of epidural steroid injection in patients who has postherpetic neuralgia is well known. In this study, the purpose is whether the continous epidural steroid injection is effective or not.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Efficacy of intermittent epidural dexamethasone bolus for zoster-associated pain beyond the acute phase.
Choi EM, Chung MH, Jun JH, Chun EH, et al · · 2020 · cited 7× · PMID 32714084 · DOI 10.7150/ijms.46038
Unraveling Chronic Pain: From Mechanisms and Risks to Diagnosis and Treatment.
Dai X, Wang C, Jiang P, Mei X. · · 2026 · PMID 41930351 · DOI 10.1002/mco2.70685

Verify or expand the search:

Other trials of Dexamethasone

Trials testing the same drug.

NCT07543458 — Therapeutics for Moderate and Severe Dengue · Phase 3 · not yet recruiting
NCT07175415 — HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological · Phase 1, PHASE2 · not yet recruiting
NCT07513129 — A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients · Phase 1 · not yet recruiting
NCT07444710 — Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) · Phase 1 · not yet recruiting
NCT07387926 — Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+ · Phase 1, PHASE2 · not yet recruiting

Other Korea University Guro Hospital trials

Trials by the same sponsor.

NCT07009769 — AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy · completed
NCT06752733 — Cardiac Stunning After Electrical Cardioversion · active not recruiting
NCT06202690 — SP Robotic Versus VATS Anatomical Pulmonary Resection for Patients With NSCLC · NA · not yet recruiting
NCT06889259 — Efficacy and Safety of CBT on Tinnitus · NA · completed
NCT05704621 — Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Mai · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03995563 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Korea University Guro Hospital
Last refreshed: 24 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03995563.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing